{
    "eid": "2-s2.0-85168449679",
    "title": "Homocysteine, vitamin B metabolites, dopamine-substituting compounds, and symptomatology in Parkinson\u2019s disease: clinical and therapeutic considerations",
    "cover-date": "2023-01-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Neurology",
            "@code": "2808",
            "@abbrev": "NEUR"
        },
        {
            "@_fa": "true",
            "$": "Neurology (clinical)",
            "@code": "2728",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Psychiatry and Mental Health",
            "@code": "2738",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Biological Psychiatry",
            "@code": "2803",
            "@abbrev": "NEUR"
        }
    ],
    "keywords": [
        "Homocysteine",
        "Levodopa",
        "Neuropathy",
        "Parkinson\u2019s disease",
        "Vitamin B metabolites"
    ],
    "authors": [
        "Onanong Phokaewvarangkul",
        "Roongroj Bhidayasiri",
        "Pedro Garcia-Ruiz",
        "Per Odin",
        "Peter Riederer",
        "Thomas M\u00fcller"
    ],
    "citedby-count": 0,
    "ref-count": 97,
    "ref-list": [
        "Dietary intake and olfactory function in patients with newly diagnosed Parkinson's disease: a case-control study",
        "Effects of vitamin B12, folate, and entacapone on homocysteine levels in levodopa-treated Parkinson's disease patients: a randomized controlled study",
        "Levodopa and 3-OMD levels in Parkinson patients treated with Duodopa",
        "Refractory status epilepticus due to vitamin B(6) deficit in a Parkinson's disease patient in treatment with levodopa/carbidopa intestinal gel",
        "Hyperhomocysteinemia recurrence in levodopa-treated Parkinson's disease patients",
        "Survival and cause of death in a cohort of patients with parkinsonism: Possible clues to aetiology?",
        "Genetic and environmental factors for hyperhomocysteinaemia and its clinical implications in Parkinson's disease",
        "Dietary approaches to improve efficacy and control side effects of levodopa therapy in Parkinson's disease: a systematic review",
        "Polyneuropathy and folate deficiency",
        "The clinical potential of ademetionine (S-adenosylmethionine) in neurological disorders",
        "Methylation demand: a key determinant of homocysteine metabolism",
        "Neuropathy and levodopa in Parkinson's disease: evidence from a multicenter study",
        "Folate intake and risk of Parkinson's disease",
        "Gastrectomy, vitamin B12 supplementation and the risk of Parkinson's disease: a nationwide cohort study",
        "Vitamin B12 and homocysteine levels predict different outcomes in early Parkinson's disease",
        "Relationship of cerebrospinal fluid vitamin B12 status markers with Parkinson's disease progression",
        "Dietary folate, vitamin B12, and vitamin B6 and the risk of Parkinson disease",
        "Levodopa and the progression of Parkinson's disease",
        "Role of homocysteine in the development and progression of Parkinson's disease",
        "Neuropsychiatric features, health-related quality of life, and caregiver burden in Parkinson's disease",
        "Intake of vitamin B before onset of Parkinson's disease and atypical parkinsonism and olfactory function at the time of diagnosis",
        "Plasma homocysteine levels and Parkinson disease: disease progression, carotid intima-media thickness and neuropsychiatric complications",
        "L-Dopa therapy increases homocysteine concentration in cerebrospinal fluid from patients with Parkinson's disease",
        "Neuropathy in Parkinson's disease patients with intestinal levodopa infusion versus oral drugs",
        "Malnutritional neuropathy under intestinal levodopa infusion",
        "Homocysteine levels in Parkinson's disease: Is entacapone effective?",
        "Elevated plasma levels of homocysteine in Parkinson's disease",
        "Effects of levodopa and COMT inhibitors on plasma homocysteine in Parkinson's disease patients",
        "Hyperhomocysteinemia due to levodopa treatment as a risk factor for osteoporosis in patients with Parkinson's disease",
        "Homocysteine and cognitive function in Parkinson's disease",
        "Neurotoxicity associated with dual actions of homocysteine at the N-methyl-d-aspartate receptor",
        "Vitamins B6 and B12, levodopa, and their complex interactions in patients with Parkinson's disease",
        "Effects of levodopa/carbidopa intestinal gel versus oral levodopa/carbidopa on B vitamin levels and neuropathy",
        "Homocysteine and Parkinson's disease: A dangerous liaison?",
        "Impact of advanced Parkinson's disease on caregivers: an international real-world study",
        "Higher vitamin B12 level at Parkinson's disease diagnosis is associated with lower risk of future dementia",
        "Homocysteine metabolism, atherosclerosis, and diseases of aging",
        "Peripheral neuropathy associated with levodopa\u2013carbidopa intestinal infusion: a long-term prospective assessment",
        "Homocysteine, vitamin B6, and vascular disease in AD patients",
        "Labile methyl group balances in the human: the role of sarcosine",
        "Role of homocysteine in the treatment of Parkinson's disease",
        "Motor complications, levodopa metabolism and progression of Parkinson's disease",
        "What are the main considerations when prescribing pharmacotherapy for Parkinson's disease?",
        "Tolcapone decreases plasma levels of S-adenosyl-l-homocysteine and homocysteine in treated Parkinson's disease patients",
        "Homocysteine levels after acute levodopa intake in patients with Parkinson's disease",
        "Peripheral COMT inhibition prevents levodopa associated homocysteine increase",
        "Nigral endothelial dysfunction, homocysteine, and Parkinson's disease",
        "3-OMD and homocysteine plasma levels in parkinsonian patients",
        "Levodopa-associated increase of homocysteine levels and sural axonal neurodegeneration",
        "Pharmacokinetic behaviour of levodopa and 3-O-methyldopa after repeat administration of levodopa/carbidopa with and without entacapone in patients with Parkinson's disease",
        "Elevation of total homocysteine levels in patients with Parkinson's disease treated with duodenal levodopa/carbidopa gel",
        "Elevation of total homocysteine levels in patients with Parkinson's disease treated with duodenal levodopa/carbidopa gel",
        "Inhibition of catechol-O-methyltransferase modifies acute homocysteine rise during repeated levodopa application in patients with Parkinson's disease",
        "Peripheral neuropathy in Parkinson's disease: levodopa exposure and implications for duodenal delivery",
        "Methyl group-donating vitamins elevate 3-O-methyldopa in patients with Parkinson disease",
        "Effects of one-day application of levodopa/carbidopa/entacapone versus levodopa/carbidopa/opicapone in Parkinson's disease patients",
        "Hypertrophy of IMC of carotid artery in Parkinson's disease is associated with L-DOPA, homocysteine, and MTHFR genotype",
        "Effect of levodopa and entacapone treatment on plasma homocysteine levels in Parkinson's disease patients",
        "Pulsatile stimulation of dopamine receptors and levodopa-induced motor complications in Parkinson's disease: implications for the early use of COMT inhibitors",
        "The effect of entacapone on homocysteine levels in Parkinson disease",
        "Modest increase in plasma homocysteine follows levodopa initiation in Parkinson's disease",
        "Clinical course in Parkinson's disease with elevated homocysteine",
        "Plasma homocysteine levels in patients treated with levodopa: motor and cognitive associations",
        "Plasma homocysteine levels in pergolide-treated Parkinson disease patients",
        "Polyneuropathy monitoring in Parkinson's disease patients treated with levodopa/carbidopa intestinal gel",
        "Vitamins and entacapone in levodopa-induced hyperhomocysteinemia: a randomized controlled study",
        "Diagnostic staging of Parkinson's disease: conceptual aspects",
        "Levodopa, vitamins, ageing and the neuropathy of Parkinson's disease",
        "Prevalence and risk factors of peripheral neuropathy in Parkinson's disease",
        "Heterogeneity and lack of good quality studies limit association between folate, vitamins B-6 and B-12, and cognitive function",
        "Peripheral neuropathy in 30 duodopa patients with vitamins B supplementation",
        "Levodopa-induced neuropathy: a systematic review",
        "Neuropsychiatric manifestations in vitamin B12 deficiency",
        "Increased homocysteine levels correlate with cortical structural damage in Parkinson's disease",
        "Clinical management of patients with advanced Parkinson's disease treated with continuous intestinal infusion of levodopa/carbidopa",
        "Predictors of the change in burden, strain, mood, and quality of life among caregivers of Parkinson's disease patients",
        "Effect of L-dopa on plasma homocysteine in PD patients: relationship to B-vitamin status",
        "Associations between B vitamins and Parkinson's disease",
        "Hydrolysis of homocysteine thiolactone results in the formation of protein-cys-S-S-homocysteinylation",
        "Refractory epileptic seizures due to vitamin B6 deficiency in a patient with Parkinson's disease under duodopa(R) therapy",
        "The molecular and cellular effect of homocysteine metabolism imbalance on human health",
        "Clinical significance of homocysteine (hcy) on dementia in Parkinson's disease (PD)",
        "Vitamins and infusion of levodopa\u2013carbidopa intestinal gel",
        "A prospective study on the relationship between iron supplement intake, hemoglobin concentration, and risk of Parkinsonism",
        "Homocysteine metabolism and various consequences of folate deficiency",
        "Neuropathy as a potential complication of levodopa use in Parkinson's disease",
        "Levodopa, methylmalonic acid, and neuropathy in idiopathic Parkinson disease",
        "Total homocysteine in plasma or serum: methods and clinical applications",
        "The impact of metabolism on DNA methylation",
        "Reduced plasma homocysteine levels in levodopa/entacapone treated Parkinson patients",
        "Olfactory function, eating ability, and visceral obesity associated with MMSE three years after Parkinson's disease diagnosis",
        "Diagnosis and treatment of cognitive and neuropsychiatric symptoms in Parkinson disease and dementia with lewy bodies",
        "The controversy concerning plasma homocysteine in Parkinson disease patients treated with levodopa alone or with entacapone: effects of vitamin status",
        "The combination of homocysteine and C-reactive protein predicts the outcomes of Chinese patients with Parkinson's disease and vascular parkinsonism",
        "Elevation of plasma homocysteine and minor hallucinations in Parkinson's disease: a cross-sectional study",
        "Plasma homocysteine levels in Parkinson's disease: role of antiparkinsonian medications",
        "Plasma homocysteine levels in L-dopa-treated Parkinson's disease patients with cognitive dysfunctions"
    ],
    "affiliation": [
        {
            "affiliation-city": "Lund",
            "@id": "60118584",
            "affilname": "Institutionen f\u00f6r Kliniska Vetenskaper, Lund",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60118584",
            "affiliation-country": "Sweden"
        },
        {
            "affiliation-city": "Wurzburg",
            "@id": "60032515",
            "affilname": "Universit\u00e4tsklinikum W\u00fcrzburg",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60032515",
            "affiliation-country": "Germany"
        },
        {
            "affiliation-city": "Madrid",
            "@id": "60026796",
            "affilname": "Universidad Aut\u00f3noma de Madrid",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60026796",
            "affiliation-country": "Spain"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60022183",
            "affilname": "King Chulalongkorn Memorial Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "113736755",
            "affilname": "Academy of Science",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/113736755",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Berlin",
            "@id": "112867597",
            "affilname": "St. Joseph Hospital Berlin-Weissensee",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/112867597",
            "affiliation-country": "Germany"
        }
    ],
    "funding": []
}